• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

3 Stocks From Jim Cramer to Consider for Your Stock Market Shopping List

Think Yum Brands, Costco and RH, all of which have little to no Chinese exposure.
By BRUCE KAMICH
Aug 02, 2019 | 01:53 PM EDT
Stocks quotes in this article: YUM, COST, RH

With the 10-year Treasury bond yield slipping below 2%, which stocks should be on investors' shopping lists? Here's what Jim Cramer said, "It's complicated," but he offered up some ideas on his Mad Money program Thursday night.

In this environment, investors can afford to be patient however, so there's no hurry to rush out and buy. Next, he said U.S. companies with scale can still work. Think Yum Brands (YUM) , Costco (COST) and RH (RH) , all of which have little to no Chinese exposure as well.

Let's peek at three charts just to get a feel for when we should look to be a buyer.

In this daily bar chart of YUM, below, we can see can see an uptrend the past 12 months. Prices gapped higher the other day in what could turn out to be a spike with an exhaustion gap. A retreat to retest the rising 50-day moving average line may be a buying opportunity if the decline is dragged out several weeks.

The rising 200-day line is another location that may be a buying location in the $100 this fall. I just gave your two locations and two time frames. What's up with that? It all depends, in my opinion, how long the broad market corrects.

Meanwhile, the On-Balance-Volume (OBV) line is rising and the Moving Average Convergence Divergence (MACD) oscillator just turned up to a fresh buy signal.

In this daily bar chart of COST, below, we can see a stock that is showing a bit more weakness than YUM.

The slope of the 50-day moving average line is starting to crest and the OBV line is weakening. The MACD oscillator has turned lower to generate a take profits sell signal.

COST could pull back to key support in the $250-$240 area in the weeks ahead. With the 200-day line intersecting just below $240 now, this area may become a level to approach the long side, but let's not be in a rush.

In this daily bar chart of RH, below, we a very different trading pattern. Instead of a clearly defined uptrend for RH we see an irregular sideways pattern.

The current rally does not mirror the board market and only gets going in June. After a gap to the upside in June the trading volume dries up and the OBV line struggles to move higher.

This is not the kind of pattern I like to see so I would not be looking to put RH on a shopping list for now.

Bottom line strategy: Creating shopping lists for the stock market is a good idea so you can be ready to execute purchases when the market turns. With any list you need to be flexible in case the story changes or you find a better, more compelling story. In the meanwhile I would keep your powder dry.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Markets | Stocks | Technical Analysis | Trading | China | Mad Money

More from Investing

Does Halozyme Therapeutics, My Q2 Pick, Still Have a HALO Over It?

Bruce Kamich
Jul 1, 2022 1:13 PM EDT

Let's check the charts on this biotechnology stock and see if it still has a prayer.

Shares of Xencor Could Be Bought on a 50% Correction

Bruce Kamich
Jul 1, 2022 11:59 AM EDT

Traders should remain patient.

Let's Size Up the Market's Prospects for the Second Half of 2022

Bret Jensen
Jul 1, 2022 11:30 AM EDT

The next six months can't be worse than the first six, can they?

In an Ugly First Half for Stocks, Value Was a Lot Less Ugly Than Growth

Jonathan Heller
Jul 1, 2022 11:00 AM EDT

A look at the Russell indexes shows that value stocks suffered in the first six months of 2022 but not nearly as much as growth issues.

Nuvalent Has Begun the Bottoming Process

Bruce Kamich
Jul 1, 2022 10:52 AM EDT

Let's check the charts and indicators.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:59 PM EDT PAUL PRICE

    Very good quarterly numbers from Bassett Furniture (BSET)

    Bassett Furniture (BSET) blew right through analys...
  • 04:41 PM EDT PAUL PRICE

    First Half Results - Putrid Second Half Results - Likely to Be Much Better

    It's great that we're done with June. 2022 marked...
  • 04:51 PM EDT PAUL PRICE

    We Should Be in for Better Starting Soon

    Window dressing Thursday, the last day of the...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login